After reiewing the issues raised in the petition, FDA determined that its standards for approal of the generic drug application for bupropion are appropriate.
And what they showed is that at lower concentrations, C-15's cell-based phenotypic profile matched that of bupropion, which is one of the leading antidepressant drugs.